Results 111 to 120 of about 240,105 (210)

Melatonergic Receptors Mediate Reduction in Ethanol Consumption in Wistar Rats. [PDF]

Biomolecules
Rather ZA, Ullal SD, Baregundi MY, Shenoy AK.   +3 more
europepmc   +1 more source

Evaluation of AT121 versus morphine on cortical neurons electrophysiology and dopamine concentrations in hippocampal cells. [PDF]

PLoS One
Elawy BE, Soukkarieh CE, Abbady AQ, Allaham SA, Deeb GM.   +4 more
europepmc   +1 more source

Brain Amylin Signaling, Feeding, and Reward. [PDF]

Compr Physiol
Mietlicki-Baase EG.
europepmc   +1 more source

No New Relevant Treatment Options for L-DOPA-Induced Dyskinesia from a Clinician's Point of View. [PDF]

Neurol Int
Müller T.
europepmc   +1 more source

Gut-Brain Signaling in Parkinson's Disease: A Narrative Review. [PDF]

Int J Mol Sci
Ratajczyk K, Kaczorowska E, Wyka K, Tarasiuk-Zawadzka A, Fichna J, Gajos A.   +5 more
europepmc   +1 more source

Molecular Pathogenesis of Memory Impairment in Parkinson's Disease: An Exploration of Underlying Mechanisms. [PDF]

Health Sci Rep
Pourfridoni M, Hakemi Z, Mashayekhi-Sardoo H, Baghcheghi Y.   +3 more
europepmc   +1 more source

Dopamine's secret agent: serotonin. [PDF]

Trends Neurosci
Miller-Hansen AJ, Lerner TN.
europepmc   +1 more source

Virtual and CMC-Based Screening Identified Reticuline, an Intermediate of BIA Biosynthesis, as a Potential Agonist of D5R. [PDF]

Molecules
Mo J, Sun Z, Xu G, Zhang G, Xie Z, Zhao J, Heng GP, Cong Z, Leng L, Chen S.   +9 more
europepmc   +1 more source

Neurotransmitter Systems in Alzheimer's Disease. [PDF]

Curr Issues Mol Biol
Ramírez-Expósito MJ, Cueto-Ureña C, Martínez-Martos JM.   +2 more
europepmc   +1 more source

Aryl-Boroxazolidones with Low In Vitro Neurotoxicity and Alleviative Effects on MPTP-Induced Parkinsonism in Mice. [PDF]

Biomolecules
Abad-García A, Bello M, Hernández-Rodríguez M, Torres-Deviana IY, García-Guzmán JA, Cruz-Aguayo KA, Barrón-González M, Trujillo-Ferrara JG, Centurion D, Soriano-Ursúa MA.   +9 more
europepmc   +1 more source